参考文献/References:
[1] Galie N,Humbert M,Vachiery JL,et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):Endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC),International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J,2016,37(1):67-119.
[2] Humbert M,Guignabert C,Bonnet S,et al. Pathology and pathobiology of pulmonary hypertension:state of the art and research perspectives[J]. Eur Respir J,2019,53(1):1801887.
[3] Naeije R,Saggar R,Badesch D,et al. Exercise-induced pulmonary hypertension:translating pathophysiological concepts into clinical practice[J]. Chest,2018,154(1):10-15.
[4] Simonneau G,Montani D,Celermajer DS,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J,2019,53(1):1801913.
[5] Fishman AP,Fisher?AB. Handbook of physiology,Sec.3:The respiratory system:Circulation and nonrespiratory functions[M]. Bethesda,MD:American Physiological Soc,1985.
[6] Kovacs G,Berghold A,Scheidl S,et al. Pulmonary arterial pressure during rest and exercise in healthy subjects:a systematic review[J]. Eur Respir J,2009,34(4):888-894.
[7] Badesch DB,Champion HC,Sanchez MA,et al. Diagnosis and assessment of pulmonary arterial hypertension[J]. J Am Coll Cardiol,2009,54(1 Suppl):S55-S66.
[8] Hoeper MM,Bogaard HJ,Condliffe R,et al. Definitions and diagnosis of pulmonary hypertension[J]. J Am Coll Cardiol,2013,62(25 Suppl):D42-D50.
[9] Kovacs G,Olschewski A,Berghold A,et al. Pulmonary vascular resistances during exercise in normal subjects:a systematic review[J]. Eur Respir J,2012,39(2):319-328.
[10] Argiento P,Vanderpool RR,Mule M,et al. Exercise stress echocardiography of the pulmonary circulation:limits of normal and sex differences[J]. Chest,2012,142(5):1158-1165.
[11] Kovacs G,Herve P,Barbera JA,et al. An official European Respiratory Society statement:pulmonary haemodynamics during exercise[J]. Eur Respir J,2017,50(5):1700578.
[12] Herve P,Lau EM,Sitbon O,et al. Criteria for diagnosis of exercise pulmonary hypertension[J]. Eur Respir J,2015,46(3):728-737.
[13] Hoeper MM. Exercise pulmonary hypertension is back[J]. J Am Coll Cardiol,2020,75(1):27-28.
[14] Reeves JT,Dempsey J,Grover FR. Pulmonary circulation during exercise[M]//Weir EK,Reeves JT. Pulmonary vascular physiology and physiopathology. New York:Marcel Dekker,1989:107-133.
[15] Naeije R,Vanderpool R,Dhakal BP,et al. Exercise-induced pulmonary hypertension:physiological basis and methodological concerns[J]. Am J Respir Crit Care Med,2013,187(6):576-583.
[16] Borlaug BA,Kane GC,Melenovsky V,et al. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction[J]. Eur Heart J,2016,37(43):3293-3302.
[17] Andersen MJ,Hwang SJ,Kane GC,et al. Enhanced pulmonary vasodilator reserve and abnormal right ventricular:pulmonary artery coupling in heart failure with preserved ejection fraction[J]. Circ Heart Fail,2015,8(3):542-550.
[18] Lewis GD,Murphy RM,Shah RV,et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes[J]. Circ Heart Fail,2011,4(3):276-285.
[19] Tumminello G,Lancellotti P,Lempereur M,et al. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure[J]. Eur Heart J,2007,28(5):569-574.
[20] Maréchaux S,Pin?on C,Le Tourneau T,et al. Cardiac correlates of exercise induced pulmonary hypertension in patients with chronic heart failure due to left ventricular systolic dysfunction[J]. Echocardiography,2008,25(4):386-393.
[21] Skj?rten I,Hilde JM,Melsom MN,et al. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension[J]. Int J Chron Obstruct Pulmon Dis ,2018,13 3599-3610.
[22] Hilde JM,Skjorten I,Hansteen V,et al. Haemodynamic responses to exercise in patients with COPD[J]. Eur Respir J,2013,41(5):1031-1041.
[23] Degani-Costa LH,Levarge B,Digumarthy SR,et al. Pulmonary vascular response patterns during exercise in interstitial lung disease[J]. Eur Respir J,2015,46(3):738-749.
[24] Kovacs G,Avian A,Tscherner M,et al. Characterization of patients with borderline pulmonary arterial pressure[J]. Chest,2014,146(6):1486-1493.
[25] Kusunose K,Yamada H,Nishio S,et al. Pulmonary artery hypertension-specific therapy improves exercise tolerance and outcomes in exercise-induced pulmonary hypertension[J]. JACC Cardiovasc Imaging,2019,12(12):2576-2579.
[26] Tolle JJ,Waxman AB,van Horn TL,et al. Exercise-induced pulmonary arterial hypertension[J]. Circulation,2008,118(21):2183-2189.
[27] Lau EM,Godinas L,Sitbon O,et al. Resting pulmonary artery pressure of 21-24 mm Hg predicts abnormal exercise haemodynamics[J]. Eur Respir J,2016,47(5):1436-1444.
[28] Condliffe R,Kiely DG,Peacock AJ,et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era[J]. Am J Respir Crit Care Med,2009,179(2):151-157.
[29] Kusunose K,Yamada H,Hotchi J,et al. Prediction of future overt pulmonary hypertension by 6-min walk stress echocardiography in patients with connective tissue disease[J]. J Am Coll Cardiol,2015,66(4):376-384.
[30] Ho JE,Zern EK,Lau ES,et al. Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort[J]. J Am Coll Cardiol,2020,75(1):17-26.
相似文献/References:
[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(10):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(10):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(10):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(10):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[5]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(10):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[6]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(10):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[7]李岳,余辉,王建旗.高强度间歇训练在心血管疾病预防和管理中的应用进展[J].心血管病学进展,2020,(3):227.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.003]
LI Yue,YU Hui,WANG Jianqi.High-intensity Interval Training in Prevention and Management of Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(10):227.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.003]
[8]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(10):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[9]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(10):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[10]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(10):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]